Vedolizumab Approval Supported, But Committee Differs on Indicated Population
This article was originally published in The Pink Sheet Daily
Executive Summary
Entyvio gains recommendation for approval in ulcerative colitis and Crohn’s disease from a joint GI and drug safety advisory committee, but concerns about indicated population may shape use; weather problems forced a shortened meeting.